Long-term Reduction of Relapse Rate and Confirmed Disability progression after 5 years of Ocrelizumab Treatment in Patients with Relapsing Multiple Sclerosis
Titel:
Long-term Reduction of Relapse Rate and Confirmed Disability progression after 5 years of Ocrelizumab Treatment in Patients with Relapsing Multiple Sclerosis
Auteur:
Hauser, S.L. Brochet, B. Montalban, X. Naismith, R.T. Wolinsky, J.S. Manfrini, M. Garas, M. Villoslada, P. Model, F. Hubeaux, S. Kappos, L.